Preferential sensitivity of hematopoietic (HPs) and mesenchymal (MPs) progenitors to fludarabine suggests impaired bone marrow niche and HP mobilization.

Authors :: Berger, M. G.
Berger, J.
Richard, C.
Jeanpierre, S.
Nicolini, F. E.
Tournilhac, O.
Michallet, M.
Satta, V. M.
Source :: Leukemia (08876924). Nov2008, Vol. 22 Issue 11, p2131-2134. 4p. 2 Graphs.
Publication Year :: 2008
Abstract: A letter to the editor is presented which is about sensitivity of hematopoietic (HPs) and mesenchymal (MPs) progenitors to fludarabine with regard to HP mobilization and impaired bone marrow niche.

Full Text Access

Tools